Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its target price lowered by stock analysts at Citigroup from $43.00 to $40.00 in a report released on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup’s price target points to a potential upside of 15.37% from the stock’s previous close.
Several other analysts also recently weighed in on KDP. Wells Fargo & Company reduced their target price on Keurig Dr Pepper from $43.00 to $42.00 and set an “overweight” rating for the company in a report on Friday. Royal Bank of Canada upped their price objective on Keurig Dr Pepper from $41.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday. Evercore ISI raised Keurig Dr Pepper to a “hold” rating in a research note on Thursday, September 5th. Barclays upped their price objective on Keurig Dr Pepper from $37.00 to $41.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Keurig Dr Pepper from $36.00 to $37.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, Keurig Dr Pepper presently has an average rating of “Moderate Buy” and an average price target of $38.50.
Get Our Latest Analysis on KDP
Keurig Dr Pepper Stock Down 0.8 %
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last announced its quarterly earnings results on Thursday, October 24th. The company reported $0.51 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.51. Keurig Dr Pepper had a return on equity of 10.32% and a net margin of 14.47%. The company had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.92 billion. During the same period in the previous year, the business earned $0.48 EPS. Keurig Dr Pepper’s revenue for the quarter was up 2.3% on a year-over-year basis. On average, equities research analysts anticipate that Keurig Dr Pepper will post 1.92 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in the company. CX Institutional raised its position in shares of Keurig Dr Pepper by 3.6% in the 3rd quarter. CX Institutional now owns 8,129 shares of the company’s stock worth $305,000 after buying an additional 283 shares during the period. Bay Colony Advisory Group Inc d b a Bay Colony Advisors increased its holdings in Keurig Dr Pepper by 3.6% in the 3rd quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 8,535 shares of the company’s stock valued at $320,000 after purchasing an additional 300 shares in the last quarter. Farmers & Merchants Investments Inc. increased its holdings in Keurig Dr Pepper by 51.5% in the 2nd quarter. Farmers & Merchants Investments Inc. now owns 886 shares of the company’s stock valued at $30,000 after purchasing an additional 301 shares in the last quarter. Federated Hermes Inc. increased its holdings in Keurig Dr Pepper by 21.8% in the 2nd quarter. Federated Hermes Inc. now owns 1,757 shares of the company’s stock valued at $59,000 after purchasing an additional 314 shares in the last quarter. Finally, Mather Group LLC. increased its holdings in Keurig Dr Pepper by 29.0% in the 2nd quarter. Mather Group LLC. now owns 1,742 shares of the company’s stock valued at $53,000 after purchasing an additional 392 shares in the last quarter. 85.23% of the stock is owned by hedge funds and other institutional investors.
About Keurig Dr Pepper
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Further Reading
- Five stocks we like better than Keurig Dr Pepper
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Texas Roadhouse Stock Steering for New Highs This Year
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What is a buyback in stocks? A comprehensive guide for investors
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.